文献速递胸部肿瘤放疗放疗物理与技术

局部晚期非小细胞肺癌碳离子与光子放疗的NTCP分析衍生相对生物效应

Relative Biological Effectiveness Derived from NTCP Analysis of Carbon Ion vs. Photon Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2025-07-21

本研究基于局部晚期非小细胞肺癌患者,采用倾向性评分匹配比较碳离子放疗与光子放疗,利用Lyman-Kutcher-Burman模型对≥2级急性放射性肺炎进行NTCP建模,由两组TD₅₀比值估算相对生物效应。结果显示碳离子组TD₅₀为15.70 Gy,光子组为41.79 Gy,估算RBE为2.66,模型区分度中等,结论需更大临床数据集验证。

要点

  • 碳离子放疗组急性RP的TD₅₀为15.70 Gy,光子组为41.79 Gy。
  • 由两组TD₅₀比值估算的急性RP相对生物效应为2.66。
  • Lyman-Kutcher-Burman模型交叉验证AUC碳离子0.63、光子0.71。

核心结论

  • 基于NTCP模型TD₅₀比值估算的碳离子放疗对急性放射性肺炎的RBE为2.66,需更大临床数据集进一步验证。

研究设计与样本

  • 主要终点为≥2级急性放射性肺炎发生率,采用Lyman-Kutcher-Burman模型基于肺剂量体积直方图建模,以5折交叉验证和ROC曲线下面积评估模型性能。

主要发现

  • 碳离子组Lyman-Kutcher-Burman模型参数为m=0.50、n=0.83、TD₅₀=15.70 Gy,光子组为m=0.28、n=0.57、TD₅₀=41.79 Gy。
  • 平均ROC曲线下面积碳离子组为0.63±0.16,光子组为0.71±0.11。
  • 由光子组与碳离子组TD₅₀比值估算的急性放射性肺炎RBE为2.66。

关键数值与推荐

  • 急性放射性肺炎NTCP模型TD₅₀:碳离子放疗15.70 Gy,光子放疗41.79 Gy。
  • 模型参数:碳离子m=0.50、n=0.83;光子m=0.28、n=0.57。
  • 模型区分度:碳离子平均AUC 0.63±0.16,光子平均AUC 0.71±0.11。
  • 估算RBE=2.66(光子TD₅₀/碳离子TD₅₀)。

临床怎么用

  • 该RBE估算值基于NTCP模型TD₅₀比值,可为碳离子放疗计划中急性放射性肺炎风险建模提供参考。
  • 模型区分度中等,临床使用前需结合更大数据集验证并谨慎解读RBE值。

局限性

  • 结论指出需更大临床数据集验证以确认这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To estimate the relative biological effectiveness (RBE) of carbon-ion radiation therapy (CIRT) compared to photon radiation therapy using the equivalent uniform dose corresponding to a 50% complication probability (TD₅₀) values derived from normal tissue complication probability (NTCP) modeling for acute radiation pneumonitis (RP) in patients with locally advanced non-small cell lung cancer. METHODS AND MATERIALS: Patients with locally advanced non-small cell lung cancer treated between January 2016 and December 2023 were selected. Propensity score matching was performed to pair patients who received CIRT with those treated with photon radiation therapy. The primary endpoint was the incidence of grade ≥2 acute RP. NTCP models based on the Lyman-Kutcher-Burman formalism were developed using the lung's dose-volume histogram data. Model performance was evaluated via 5-fold cross-validation and the area under the receiver operating characteristic curve. RBE was estimated as the TD₅₀ ratio between photon radiation therapy and CIRT groups. RESULTS: A total of 158 matched patients per group were analyzed. For grade ≥2 acute RP, the optimal Lyman-Kutcher-Burman model parameters were m = 0.50, n = 0.83, and TD₅₀ = 15.70 Gy (CIRT); and m = 0.28, n = 0.57, and TD₅₀ = 41.79 Gy (photon radiation therapy). The mean area under the receiver operating characteristic curve was 0.63 ± 0.16 for CIRT and 0.71 ± 0.11 for photon radiation therapy. The derived estimated RBE for acute RP was 2.66. CONCLUSIONS: The NTCP model for acute RP provides a basis for RBE estimation using TD₅₀ values. Further validation with larger clinical datasets is necessary to confirm these findings.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Liu Y, Ma N, Li Y, et al. Relative Biological Effectiveness Derived from NTCP Analysis of Carbon Ion vs. Photon Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2025. PMID: 40701500. doi:10.1016/j.ijrobp.2025.07.1420

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。